BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023
NameSharesValueWeighting ↓
ACADIAN ASSET MANAGEMENT LLC 53,365$2680.00%
Citadel Advisors 1,215,408$6,137,8110.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 271,207$1,369,5950.00%
STATE STREET CORP 76,384$385,7390.00%
MILLENNIUM MANAGEMENT LLC 64,400$325,2200.00%
Cutler Group LLC / CA 300$10.00%
US BANCORP \DE\ 700$3,5350.00%
DIMENSIONAL FUND ADVISORS LP 17,087$86,2890.00%
STATE OF WISCONSIN INVESTMENT BOARD 12,100$61,1050.00%
HSBC HOLDINGS PLC 24,156$119,5720.00%
SALEM INVESTMENT COUNSELORS INC 35$1770.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 14,484$73,1440.00%
FMR LLC 18$920.00%
MORGAN STANLEY 16,269$82,1580.00%
TSFG, LLC 100$10.00%
BANK OF MONTREAL /CAN/ 15,000$76,3500.00%
BlackRock Inc. 1,505,439$7,602,4680.00%
Citadel Advisors 110,200$556,5100.00%
Citadel Advisors 3,800$19,1900.00%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q2 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.